Please sign in to follow a disease.
Oligoastrocytoma
MONDO:0016702A WHO grade II tumor composed of a conspicuous mixture of two distinct neoplastic cell types morphologically resembling the tumor cells in oligodendroglioma and diffuse astrocytoma. (WHO)
Also known as: MOA, WHO grade II mixed glioma, glioma, mixed, benign, mixed astrocytic-oligodendroglial neoplasm, mixed astrocytic-oligodendroglial tumor, mixed astrocytic-oligodendroglial tumour, mixed astrocytoma-oligodendroglioma, mixed oligo-astrocytoma
1466 clinical trials for this condition and its sub-types, 6 tagged with Oligoastrocytoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Oligoastrocytoma
-
Anaplastic oligoastrocytoma 12 trials
-
Brain radiation showdown: proton vs. photon – which saves your mind?
Disease control OngoingThis study compares two radiation methods—proton beam and photon beam (IMRT)—in 120 people with slow-growing brain tumors (IDH-mutant gliomas). The goal is to see which better preserves memory and thinking over time. Participants are randomly assigned to one type of radiation and…
Phase 2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Virus therapy takes on brain cancer in early trial
Disease control OngoingThis early-stage study tests a genetically engineered virus (rQNestin34.5v.2) that is injected directly into recurrent brain tumors to see if it is safe and what dose works best. About 62 adults with certain types of brain cancer that have come back or worsened are taking part. T…
Phase 1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Stem cells and immunotherapy join forces against childhood brain tumors
Disease control OngoingThis early-stage trial tests a new approach for children whose high-grade glioma has come back after standard treatments. It combines specially grown stem cells with an immunotherapy drug called nivolumab. The main goals are to see if the treatment is safe and possible to deliver…
Phase 1 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could adding chemo to radiation tame Slow-Growing brain tumors?
Disease control OngoingThis phase 3 trial compares radiation therapy alone versus radiation plus the chemotherapy drug temozolomide for people with symptomatic or progressive low-grade gliomas. The study enrolled 540 adults and aims to see if adding chemo improves how long patients live without their t…
Phase 3 • Sponsor: Eastern Cooperative Oncology Group • Aim: Disease control
Last updated Jun 26, 2026 14:25 UTC